Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat

Industry Overview - Winter wheat is a crucial crop in North America and globally, contributing significantly to the agricultural economy and food supply, with the US expected to produce about 1.28 billion bushels in 2024, valued between $5-$10 billion annually [1][7] - The US soybean market size is estimated at approximately $56.2 billion in 2024, indicating substantial market potential for agricultural innovations [2] Company Overview - Lavie Bio is focused on enhancing crop productivity and sustainability through its product Yalos™, which has shown improved early vigor, biomass, root and shoot development, nutrient availability, and feed quality in winter wheat during field trials [7][8] - The company aims to expand Yalos™ into other key crops, such as soybean and canola, with ongoing field trials and an expected commercial launch in 2025 [2][8] - Lavie Bio utilizes a proprietary computational predictive platform, the BDD platform, powered by Evogene's MicroBoost AI technology, to discover and develop bio-stimulant and bio-pesticide products [8][9] Strategic Goals - Lavie Bio's strategy includes consistently introducing innovative ag-biological products to the market while expanding existing products to more crops and regions, reinforcing its commitment to advancing agricultural productivity and sustainability globally [8] - The company aims for Yalos™ to become a leading solution for growers in all major field crops, addressing key growth challenges and enhancing plant health and yield [8]